Polyphor AG

Swiss Biotech Association

Member
Claim / update listing

Polyphor is a clinical stage biopharmaceutical company focused on the discovery and development of immuno-oncology compounds and a new class of antibiotics against Gram-negative bacteria, the Outer Membrane Protein Targeting Antibiotics (OMPTA).

https://www.polyphor.com/

Location

Hegenheimermattweg 125, 4123 Allschwil, Schweiz

Get Directions

Facts & figures

Type of organization

Public company
Year of foundation

1996
Number of employees in Switzerland

50-149

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

LATAM Pharma Innovative Ventures AG

LATAM Pharma offers made-to-measure solutions of immunization to public and private markets in Latin American and Caribbean countries.
6300 Zug

Member

Onward Therapeutics SA

We are a development stage oncology company, focusing on the identification of innovative technologies and the development of truly breakthrough medicines for the treatment of cancer.
1066 Épalinges

Member

NovaGo Therapeutics

NovaGo is focused on human antibody therapeutics targeting blood vessel & nerve growth. Our proprietary antibodies target Nogo-A, one of the most potent vascular & nerve growth inhibitors & have the potential to be a safe & effective treatment in ophthalmology and central nervous system indications.
8952 Schlieren

Member